Skip to the page

Data / Drug companies / Dexamethasone

Dexamethasone: 45 companies and 145 products in the FDA NDC directory

Dexamethasone is listed in the FDA National Drug Code Directory by 45 companies, with 145 products in commercial distribution. 141 of the products (97.2%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet; elixir; solution, and the newest product started marketing on June 8, 2026.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Companies listing it
45
Products
145
Generic (ANDA) products
141 (97.2%)
Application numbers
30
Routes
Oral, Ophthalmic, Intracanalicular, Intravitreal
Brand names
TaperDex 6-Day, Hemady, TaperDex 12-Day, Maxidex, Dextenza, Ozurdex
openFDA record search
api.fda.gov

Companies that list dexamethasone

Ranked by number of products. Finished drugs in commercial distribution.

CompanyProductsMain dosage formsMain marketing categoryNewest product started
Hikma Pharmaceuticals USA Inc.15tablet; solutionGeneric drugs (ANDA)September 15, 1983
Bryant Ranch Prepack8tabletGeneric drugs (ANDA)April 15, 2024
Advagen Pharma Ltd7tabletGeneric drugs (ANDA)October 15, 2025
Ani Pharmaceuticals, Inc.7tablet; elixirGeneric drugs (ANDA)December 1, 2025
Apotex Corp.7tabletGeneric drugs (ANDA)December 5, 2023
Viona Pharmaceuticals Inc7tabletGeneric drugs (ANDA)May 13, 2024
Zydus Lifesciences Limited7tabletGeneric drugs (ANDA)May 13, 2024
Direct_Rx6tabletGeneric drugs (ANDA)September 4, 2024
NorthStar RxLLC6tabletGeneric drugs (ANDA)November 13, 2023
Preferred Pharmaceuticals Inc.6tabletGeneric drugs (ANDA)June 8, 2026
Bryant Ranch Prepack4tabletGeneric drugs (ANDA)September 15, 1983
Advanced Rx of Tennessee, LLC3tabletGeneric drugs (ANDA)May 7, 2025
American Health Packaging3tabletGeneric drugs (ANDA)December 1, 2023
Amneal Pharmaceuticals NY LLC3tabletGeneric drugs (ANDA)September 12, 2022
Bionpharma Inc.3tabletGeneric drugs (ANDA)August 1, 2023
Cardinal Health 107, LLC3tabletGeneric drugs (ANDA)September 1, 2021
Doc Rx3tabletGeneric drugs (ANDA)September 15, 1983
Major Pharmaceuticals3tabletGeneric drugs (ANDA)August 26, 2024
NuCare Pharmaceuticals,Inc.3tabletGeneric drugs (ANDA)October 15, 2025
PD-Rx Pharmaceuticals, Inc.3tabletGeneric drugs (ANDA)November 21, 2025
Proficient Rx LP3tabletGeneric drugs (ANDA)June 28, 2021
Proficient Rx LP3tabletGeneric drugs (ANDA)November 1, 2023
Remedyrepack Inc.3tabletGeneric drugs (ANDA)May 27, 2026
Sportpharm LLC3tabletGeneric drugs (ANDA)November 1, 2023
A-S Medication Solutions2tabletGeneric drugs (ANDA)April 30, 2022
Alvogen Inc.2tabletGeneric drugs (ANDA)June 28, 2021
PD-Rx Pharmaceuticals, Inc.2tabletGeneric drugs (ANDA)July 19, 1978
Pangea Pharmaceuticals, LLC2tabletGeneric drugs (ANDA)May 1, 2026
Proficient Rx LP2tabletGeneric drugs (ANDA)August 26, 1982
Allergan, Inc.1implantNew drug applications (NDA)September 1, 2009
Bryant Ranch Prepack1elixirGeneric drugs (ANDA)November 14, 2025
Chartwell RX, LLC1elixirGeneric drugs (ANDA)May 11, 2011
Direct RX1tabletGeneric drugs (ANDA)June 15, 2020
Edenbridge Pharmaceuticals LLC.1tabletNew drug applications (NDA)October 3, 2019
Golden State Medical Supply, Inc.1tabletGeneric drugs (ANDA)January 1, 1982
Harrow Eye, LLC1for suspensionNew drug applications (NDA)April 7, 2025
Kanchan Healthcare Inc1elixirGeneric drugs (ANDA)November 14, 2025
Kesin Pharma Corporation1elixirGeneric drugs (ANDA)September 21, 1976
Marlex Pharmaceuticals, Inc.1elixirGeneric drugs (ANDA)September 21, 1976
Northwind Health Company, LLC1tabletGeneric drugs (ANDA)August 11, 2014
Ocular Therapeutix, Inc.1insertNew drug applications (NDA)January 7, 2019
PD-Rx Pharmaceuticals, Inc.1tabletGeneric drugs (ANDA)August 26, 1982
Prasco Laboratories1tabletGeneric drugs (ANDA)April 30, 2022
Redpharm Drug1tabletGeneric drugs (ANDA)June 28, 2021
Rising Pharma Holdings, Inc.1elixirGeneric drugs (ANDA)August 1, 2011

Dosage forms

Dosage formProductsShare
Tablet13492.4%
Elixir74.8%
Solution10.7%
For suspension10.7%
Insert10.7%
Implant10.7%

Marketing categories

Marketing categoryProductsShare
Generic drugs (ANDA)14197.2%
New drug applications (NDA)42.8%

Pharmacologic classes

ClassProducts
Corticosteroid145

Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.